Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc

Details for Australian Patent Application No. 2004247082 (hide)

Owner The Procter & Gamble Company

Inventors Rennie, Paul John; Sutton, Richard Matthew Charles; Khanolkar, Jayant Ekanth; McDonald, Michael Ray; De La Harpe, Shane Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004247082

PCT Pub. Number WO2004/110463

Priority 10/456,465 06.06.03 US

Filing date 1 June 2004

Wipo publication date 23 December 2004

Acceptance publication date 24 April 2008

International Classifications

A61K 31/19 (2006.01)

A61K 31/315 (2006.01)

A61K 33/30 (2006.01) Medicinal preparations containing inorganic active ingredients - Zinc

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/110463 Priority application(s): WO2004/110463

24 April 2008 Application Accepted

  Published as AU-B-2004247082

21 August 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247085-Intradermal needle

2004247081-Subcutaneous biopsy cavity marker device